2.12
前日終値:
$1.82
開ける:
$1.89
24時間の取引高:
262.76K
Relative Volume:
0.32
時価総額:
$6.78M
収益:
-
当期純損益:
$-11.27M
株価収益率:
-0.099
EPS:
-21.4132
ネットキャッシュフロー:
$-9.40M
1週間 パフォーマンス:
-6.19%
1か月 パフォーマンス:
-19.39%
6か月 パフォーマンス:
-70.14%
1年 パフォーマンス:
-84.64%
Dermata Therapeutics Inc Stock (DRMA) Company Profile
名前
Dermata Therapeutics Inc
セクター
電話
(858)-223-0882
住所
3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO
DRMA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
DRMA
Dermata Therapeutics Inc
|
2.12 | 5.82M | 0 | -11.27M | -9.40M | -21.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
454.67 | 116.86B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
758.91 | 80.72B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
810.51 | 49.26B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
369.96 | 49.00B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
351.06 | 36.96B | 4.98B | 69.59M | 525.67M | 0.5197 |
Dermata Therapeutics Inc (DRMA) 最新ニュース
How buybacks impact Dermata Therapeutics Inc. stock value2025 Trade Ideas & Verified Stock Trade Ideas - Улправда
Can Dermata Therapeutics Inc. Equity Warrant stock deliver consistent earnings growthQuarterly Profit Report & AI Based Trade Execution Alerts - Улправда
Axillary Hyperhidrosis Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Botanix Pharma, Sound Surgical Tech, Dr. August Wolff GmbH, Medy-Tox, Journey Medical Corp. - Barchart.com
Will Dermata Therapeutics Inc. stock attract more institutional investorsFit and Size Notes & support options for steady strides - Улправда
Dermata Therapeutics Inc. (DRMA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
What dividend safety score for Dermata Therapeutics Inc. Equity Warrant stockJuly 2025 Big Picture & Daily Profit Focused Screening - Улправда
Is Dermata Therapeutics Inc. stock a top pick in earnings seasonMarket Movers & Free Expert Verified Stock Movement Alerts - Улправда
Why Dermata Therapeutics Inc. Equity Warrant stock is popular among millennialsTrade Exit Summary & Smart Investment Allocation Insights - Улправда
Is Dermata Therapeutics Inc. stock a contrarian buyJuly 2025 Catalysts & Safe Entry Zone Tips - Улправда
Is Dermata Therapeutics Inc. stock trading at a premium valuationJuly 2025 Setups & Safe Entry Trade Signal Reports - Улправда
Aug Ideas: How Dermata Therapeutics Inc. Equity Warrant stock reacts to oil pricesGap Up & Scalable Portfolio Growth Methods - ulpravda.ru
Will Dermata Therapeutics Inc. stock outperform growth indexesWeekly Trade Summary & Real-Time Volume Trigger Notifications - Улправда
Why Dermata Therapeutics Inc. Equity Warrant stock is a value investor pick2025 Market Trends & Community Consensus Trade Signals - Улправда
How Dermata Therapeutics Inc. stock benefits from global expansion2025 Biggest Moves & Technical Entry and Exit Tips - Улправда
Dermata Therapeutics Inc Equity Warrant Stock Analysis and ForecastBullish Engulfing Patterns & Free Phenomenal Capital Appreciation - earlytimes.in
Pre-market Movers: RSLS, STSS, VERO, KTTA... - RTTNews
Dermata Therapeutics announces $2.55M private offering - MSN
Top 5 stocks to watch today | December 30th - MSN
Dermata Therapeutics: Is Change on the Horizon? - StocksToTrade
Dermata Therapeutics: Unveiling Bold Moves - timothysykes.com
Top 5 Stocks To Watch Today | December 30th - MSN
Stock Market Today: S&P 500, Dow Jones Futures Trade Mixed Amid Blip In Santa Claus Rally—Boeing, Freeport-McMoRan, Fonar In Focus - Benzinga
Verastem, TEN Holdings And 3 Stocks To Watch Heading Into Tuesday - Benzinga
Dermata stock surges after closing $4.1 million private placement By Investing.com - Investing.com Australia
Dermata stock surges after closing $4.1 million private placement - Investing.com
Dermata Therapeutics Signs Multiple Material Agreements - TradingView — Track All Markets
Dermata Therapeutics Announces Closing of up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Weatherford Democrat
Skincare firm Dermata raises $4.1M to back new over-the-counter acne kit - Stock Titan
Bank Watch: Why Dermata Therapeutics Inc Equity Warrant stock is popular among millennialsQuarterly Profit Report & High Accuracy Investment Entry Signals - moha.gov.vn
Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Fox21Online
Dermata Therapeutics, Inc.Warrant (NQ: DRMAW - FinancialContent
Dermata Therapeutics’ Skincare Innovation Sparks Interest - StocksToTrade
Dermata Therapeutics, Inc. (DRMA) Stock: Surges 25% as Insider-Backed $4.1M Offering Fuels Momentum - parameter.io
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Why Is Dermata Therapeutics Stock Surging Wednesday? - Sahm
Why Did Dermata Therapeutics Stock Surge 22% Pre-Market Today? - Menafn.com
Dermata Therapeutics stock soars after securing $4.1 million private placement By Investing.com - Investing.com Nigeria
Dermata Therapeutics stock soars after securing $4.1 million private placement - Investing.com Nigeria
DRMA Stocks Thrive: Time for Action? - timothysykes.com
Why did Dermata Therapeutics stock surge 22% pre-market today? - MSN
Dermata lines up as much as $12.4M to help launch OTC acne kit - Stock Titan
Ingersoll (500210) Stock RalliesVolume Profile Analysis & Investment Recommendations You Can Trust - Bollywood Helpline
Dermata Therapeutics, Inc. announced that it expects to receive $4.124468 million in funding - marketscreener.com
Quarterly Risk: How interest rate cuts could boost ESGRO stockJuly 2025 Market Mood & Free Verified High Yield Trade Plans - Улправда
Dermata Therapeutics Inc (DRMA) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):